CORRESP 1 filename1.htm

 

 

IMMURON LIMITED

Suite 1, 1233 High Street

Armadale, Victoria, Australia 3143

 

 

  May 26, 2017

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

Attn: Suzanne Hayes, Esq.

Assistant Director

 

Re: Immuron Limited
  Amendment No. 7 to Registration Statement on Form F-1
  Filed May 25, 2017
  File No. 333-215204 (the “Registration Statement”)

  

Dear Ms. Hayes:

 

We are responding to the oral comment conveyed to our counsel Sichenzia Ross Ference Kesner LLP on May 25, 2017 by the staff (the “Staff”) relating to Amendment No. 7 to the Registration Statement filed by the Company with the Securities and Exchange Commission.

 

1.Staff Oral Comment:

 

Update the legal opinions filed as exhibits to the Registration Statement to reflect the amended amount of securities being offered and sold.

 

Response:

 

The Company has filed Amendment No. 8 to the Registration Statement to include amended legal opinions attached as exhibits 5.1 and 5.2. The opinions have been revised to reference the securities set forth in Amendment No. 6 to the Registration Statement.

.

 

Should you have any questions regarding the foregoing, please do not hesitate to contact our counsel Darrin Ocasio, Esq. of Sichenzia Ross Ference Kesner LLP at (212) 930-9700.

 

 

Very truly yours,

 

  IMMURON LIMITED
   
  By: /s/ Thomas Liquard  
    Thomas Liquard, Chief Executive Officer